InvestorsHub Logo
Followers 0
Posts 2177
Boards Moderated 0
Alias Born 04/13/2018

Re: Knuckle Sandwich post# 13959

Wednesday, 08/12/2020 10:59:11 AM

Wednesday, August 12, 2020 10:59:11 AM

Post# of 42881
Of course Brazil's mailbox is open. It's one of the poorest countries in the world with most of the population unable to afford the drug.

One of two things will happen. Sub par sales because of the amount of crippling poverty in the country.

The drug will be ceased, the IP will be stolen and manufactured by the government. Brazil does have a habit of nationalizing things in crisis scenarios. That or the government will clobber Humanigen's ability to make a profit by making demands on the ability to cheaply distribute the drug.

Humanigen's big play is to go a country that is typically a day away from becoming a failed state, on human rights watchlists, and as we all saw from the Olympics an ongoing humanitarian disaster.

So for Humanigen to happily head in that direction indicates the level of desperation of the Martin Shekrli tutored CEO Cameron Durrant.

The market can see this, that's why it's teetering on uplisting failure.

GLTA